BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20040391)

  • 41. Expression of thymosin beta10 and its role in non-small cell lung cancer.
    Gu Y; Wang C; Wang Y; Qiu X; Wang E
    Hum Pathol; 2009 Jan; 40(1):117-24. PubMed ID: 18789485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
    Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
    Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
    Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular endothelial growth factor expression and neovascularization in non--small cell lung carcinoma.
    Ozbudak IH; Ozbilim G; Kucukosmanoglu I; Dertsiz L; Demircan A
    Int J Surg Pathol; 2009 Oct; 17(5):390-5. PubMed ID: 18849317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis.
    Fleischmann A; Schlomm T; Köllermann J; Sekulic N; Huland H; Mirlacher M; Sauter G; Simon R; Erbersdobler A
    Prostate; 2009 Jun; 69(9):976-81. PubMed ID: 19274666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma.
    Takanami I; Takeuchi K; Naruke M
    Cancer; 2000 Jun; 88(12):2686-92. PubMed ID: 10870050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Most peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion. Rationale for treatment with wedge resection alone.
    Macchiarini P; Fontanini G; Hardin JM; Pingitore R; Angeletti CA
    J Thorac Cardiovasc Surg; 1992 Oct; 104(4):892-9. PubMed ID: 1328770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum angiopoietin-1 as a prognostic marker in resected early stage lung cancer.
    Park JH; Choi H; Kim YB; Kim YS; Sheen SS; Choi JH; Lee HL; Lee KS; Chung WY; Lee S; Park KJ; Hwang SC; Lee KB; Park KJ
    Lung Cancer; 2009 Dec; 66(3):359-64. PubMed ID: 19339077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of angiogenesis in operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis M; O'Byrne K; Fox S; Whitehouse R; Talbot DC; Harris AL; Gatter KC
    J Pathol; 1996 May; 179(1):80-8. PubMed ID: 8691350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.
    Fontanini G; Lucchi M; Vignati S; Mussi A; Ciardiello F; De Laurentiis M; De Placido S; Basolo F; Angeletti CA; Bevilacqua G
    J Natl Cancer Inst; 1997 Jun; 89(12):881-6. PubMed ID: 9196255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of mast cells with microvessel density in urothelial carcinomas of the urinary bladder.
    Sari A; Calli A; Cakalagaoglu F; Altınboga AA; Bal K
    Ann Diagn Pathol; 2012 Jan; 16(1):1-6. PubMed ID: 22018898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The influence of microvessel density in the tumor on the prognosis in patients with stage I-II non-small cell lung cancer after surgical treatment].
    Kolesnik AP; Shevchenko AI; Tumanskiĭ VA; Evseev AV; Shishkin MA
    Vopr Onkol; 2013; 59(6):735-9. PubMed ID: 24624783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mast cells contribute to the angiogenesis in non-Hodgkin lymphoma. An immunohistochemical study based on the relationship with microvessel density.
    Duşe AO; Ceauşu RA; Mezei T; Cîmpean AM; Gaje P; Ioniţă H; Jung I
    Rom J Morphol Embryol; 2011; 52(3 Suppl):1091-6. PubMed ID: 22119830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of macrophages, mast cells and eosinophil leukocytes with angiogenesis and tumor stage in non-small cell lung carcinomas (NSCLC).
    Tataroğlu C; Kargi A; Ozkal S; Eşrefoğlu N; Akkoçlu A
    Lung Cancer; 2004 Jan; 43(1):47-54. PubMed ID: 14698536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The significance and relationship between mast cells and tumour angiogenesis in non-small cell lung carcinoma.
    Dundar E; Oner U; Peker BC; Metintas M; Isiksoy S; Ak G
    J Int Med Res; 2008; 36(1):88-95. PubMed ID: 18230272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tryptase mast cells in malignant pleural mesothelioma as an independent favorable prognostic factor.
    Alì G; Boldrini L; Lucchi M; Mussi A; Corsi V; Fontanini G
    J Thorac Oncol; 2009 Mar; 4(3):348-54. PubMed ID: 19155997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Do mast cell phenotypes play a role in concomitantly increased microvessel density and progression of non-small cell lung cancer?
    Erol AY; Ozdemir O
    Hum Pathol; 2011 Jul; 42(7):1056-7; author reply 1058-9. PubMed ID: 21683868
    [No Abstract]   [Full Text] [Related]  

  • 58. The expression of vascular endothelial growth factor in mast cells promotes the neovascularisation of human pterygia.
    Liang K; Jiang Z; Zhao B; Shen J; Huang D; Tao L
    Br J Ophthalmol; 2012 Sep; 96(9):1246-51. PubMed ID: 22790437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The relationship of mast cells and angiogenesis with prognosis in renal cell carcinoma.
    Guldur ME; Kocarslan S; Ozardali HI; Ciftci H; Dincoglu D; Gumus K
    J Pak Med Assoc; 2014 Mar; 64(3):300-3. PubMed ID: 24864604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Flattened microvessel independently predicts poor prognosis of patients with non-small cell lung cancer.
    Fang L; He Y; Tong Y; Hu L; Xin W; Liu Y; Zhong L; Zhang Y; Huang P
    Oncotarget; 2017 May; 8(18):30092-30099. PubMed ID: 28404911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.